10-Q Filing

STREAMEX CORP. CIK: 1530766 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001185185-19-001424`
Period End Date	20190930
Filing Date	20191023
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	bsgm-20190930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 60 Cash Flow Statement 69 Stockholders Equity 53

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$4.45M	USD	Point-in-time
Cash	`Cash`	$12.31M	USD	Point-in-time
Vendor deposits	`DepositAssets`	$430.44K	USD	Point-in-time
Vendor deposits	`DepositAssets`	$100.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$143.50K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$78.44K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.63M	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$9.01K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.88M	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$32.37K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$102.04K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$44.35K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$732.41K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$268.80K	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$369.29K	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$1.12K	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$850.00	USD	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	-	USD	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	$32.10K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$101.84K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$54.24K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$14.22M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total assets	`Assets`	$5.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	16.87M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	40.33M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	22.03M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	22.03M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	40.33M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	16.87M	shares	Point-in-time
Accounts payable and accrued expenses, including $9,014 and $32,366 to related parties as of September 30, 2019 and December 31, 2018, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$954.65K	USD	Point-in-time
Accounts payable and accrued expenses, including $9,014 and $32,366 to related parties as of September 30, 2019 and December 31, 2018, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$724.45K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$123.60K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$242.91K	USD	Point-in-time
Lease liability, short term	`OtherLiabilitiesCurrent`	$365.35K	USD	Point-in-time
Lease liability, short term	`OtherLiabilitiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.20M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.21M	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$375.17K	USD	Point-in-time
Total debt	`Liabilities`	$1.59M	USD	Point-in-time
Total debt	`Liabilities`	$1.20M	USD	Point-in-time
Convertible Preferred Stock	`TemporaryEquityCarryingAmountAttributableToParent`	$215.00K	USD	Point-in-time
Convertible Preferred Stock	`TemporaryEquityCarryingAmountAttributableToParent`	$475.00K	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 22,032,342 and 16,868,783 issued and outstanding as of September 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$22.03K	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 22,032,342 and 16,868,783 issued and outstanding as of September 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$16.87K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$74.04M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$101.48M	USD	Point-in-time
Subscriptions	`StockholdersEquityNoteSubscriptionsReceivable`	$501.00K	USD	Point-in-time
Subscriptions	`StockholdersEquityNoteSubscriptionsReceivable`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-89.99M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-70.73M	USD	Point-in-time
Total stockholders' equity attributable to BioSig Technologies, Inc	`StockholdersEquity`	$12.01M	USD	Point-in-time
Total stockholders' equity attributable to BioSig Technologies, Inc	`StockholdersEquity`	$3.32M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$405.67K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	-	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.42M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.25M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.97M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.55M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.08M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$14.22M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$5.00M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$3.06M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$744.17K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.64M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.95M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.41M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.84M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.49M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$14.38M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$8.81K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$36.42K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.98K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$18.51K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.15M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.50M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$11.56M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$19.37M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-3.15M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-11.56M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-19.37M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.50M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$84.62K	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$2.29K	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$1.94K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$39.35K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.15M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-5.46M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-19.28M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-11.55M	USD	3 Qtrs
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.15M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.55M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-5.46M	USD	1 Quarter
Net loss	`ProfitLoss`	$-19.28M	USD	3 Qtrs
Preferred stock dividend	`DividendsPreferredStock`	$4.88K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$20.29K	USD	3 Qtrs
Preferred stock dividend	`DividendsPreferredStock`	$194.43K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$780.35K	USD	3 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.35M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.34M	USD	3 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.47M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-19.30M	USD	3 Qtrs
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$20.54K	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$20.54K	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO BIOSIG TECHNOLOGIES, INC.	`NetIncomeLoss`	$-3.35M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO BIOSIG TECHNOLOGIES, INC.	`NetIncomeLoss`	$-5.45M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO BIOSIG TECHNOLOGIES, INC.	`NetIncomeLoss`	$-12.34M	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO BIOSIG TECHNOLOGIES, INC.	`NetIncomeLoss`	$-19.28M	USD	3 Qtrs
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.89	USD	3 Qtrs
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.25	USD	1 Quarter
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	1 Quarter
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.96	USD	3 Qtrs
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.12M	shares	3 Qtrs
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.78M	shares	3 Qtrs
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	21.81M	shares	1 Quarter
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.53M	shares	1 Quarter

Cash Flow Statement 69 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-3.15M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.55M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-5.46M	USD	1 Quarter
Net loss	`ProfitLoss`	$-19.28M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$8.81K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$36.42K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.98K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$18.51K	USD	1 Quarter
Equity based compensation	`ShareBasedCompensation`	$7.70M	USD	3 Qtrs
Equity based compensation	`ShareBasedCompensation`	$4.34M	USD	3 Qtrs
Change in fair value of modified options	`OtherNoncashExpense`	-	USD	3 Qtrs
Change in fair value of modified options	`OtherNoncashExpense`	$666.06K	USD	3 Qtrs
Vendor deposits	`IncreaseDecreaseInDepositsOutstanding`	-	USD	3 Qtrs
Vendor deposits	`IncreaseDecreaseInDepositsOutstanding`	$330.44K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$29.35K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$97.16K	USD	3 Qtrs
Security deposit	`IncreaseDecreaseInDeposits`	$-44.62K	USD	3 Qtrs
Security deposit	`IncreaseDecreaseInDeposits`	$-47.60K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$-226.83K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$-10.78K	USD	3 Qtrs
Lease liability, net	`DerivativeGainLossOnDerivativeNet`	-	USD	3 Qtrs
Lease liability, net	`DerivativeGainLossOnDerivativeNet`	$-4.73K	USD	3 Qtrs
Deferred rent payable	`IncreaseDecreaseInDeferredCharges`	-	USD	3 Qtrs
Deferred rent payable	`IncreaseDecreaseInDeferredCharges`	$-1.40K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.29M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-11.58M	USD	3 Qtrs
Payments of patent costs	`PaymentsToAcquireIntangibleAssets`	$227.85K	USD	3 Qtrs
Payments of patent costs	`PaymentsToAcquireIntangibleAssets`	$111.32K	USD	3 Qtrs
Payment of trademark costs	`PaymentsToAcquireOtherProductiveAssets`	$850.00	USD	3 Qtrs
Payment of trademark costs	`PaymentsToAcquireOtherProductiveAssets`	$275.00	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$83.30K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$21.67K	USD	3 Qtrs
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-194.89K	USD	3 Qtrs
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-250.37K	USD	3 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$8.62M	USD	3 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$9.14M	USD	3 Qtrs
Proceeds from sale of subsidiary stock to non-controlling interest	`ProceedsFromMinorityShareholders`	-	USD	3 Qtrs
Proceeds from sale of subsidiary stock to non-controlling interest	`ProceedsFromMinorityShareholders`	$3.69M	USD	3 Qtrs
Subscription received from subsidiary stock subscription from non-controlling interest	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	3 Qtrs
Subscription received from subsidiary stock subscription from non-controlling interest	`ProceedsFromPaymentsForOtherFinancingActivities`	$501.00K	USD	3 Qtrs
Proceeds from sale of Series E preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$1.49M	USD	3 Qtrs
Proceeds from sale of Series E preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	3 Qtrs
Proceeds from exercise of warrants	`ProceedsFromIssuanceOfWarrants`	$6.35M	USD	3 Qtrs
Proceeds from exercise of warrants	`ProceedsFromIssuanceOfWarrants`	$2.02M	USD	3 Qtrs
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$615.60K	USD	3 Qtrs
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$465.20K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$19.63M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.27M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$7.86M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$5.73M	USD	3 Qtrs
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.55M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$7.28M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.45M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$12.31M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.45M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$12.31M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$7.28M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.55M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaid`	-	USD	3 Qtrs
Cash paid during the period for interest	`InterestPaid`	-	USD	3 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Reclassify fair value of derivative and warrant liabilities to equity upon adoption of ASU 2017-11	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$3.04M	USD	3 Qtrs
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$780.35K	USD	3 Qtrs
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$20.29K	USD	3 Qtrs
Right-to-use assets and lease liability recorded upon adoption of ASC 842	`OtherSignificantNoncashTransactionValueOfConsiderationReceived1`	$422.21K	USD	3 Qtrs
Right-to-use assets and lease liability recorded upon adoption of ASC 842	`OtherSignificantNoncashTransactionValueOfConsiderationReceived1`	-	USD	3 Qtrs
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	3 Qtrs
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$511.24K	USD	3 Qtrs

Stockholders Equity 53 line items

Line Item	Tag	Value	Unit	Period
Common stock issued upon exercise of warrants	`ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercised`	$3.75	USD	1 Quarter
Common stock issued upon exercise of warrants	`ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercised`	$3.81	USD	3 Qtrs
Common stock issued upon exercise of warrants	`ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercised`	$4.01	USD	1 Quarter
Common stock issued upon exercise of warrants	`ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercised`	$4.02	USD	3 Qtrs
Common stock issued upon exercise of options per share	`ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice`	$4.77	USD	3 Qtrs
Common stock issued upon exercise of options per share	`ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice`	$5.09	USD	1 Quarter
Common stock issued upon exercise of options per share	`ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice`	$4.40	USD	3 Qtrs
Common stock issued upon exercise of options per share	`ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice`	$4.40	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.08M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.97M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.55M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.42M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.25M	USD	Point-in-time
Fair value reclassification	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$3.04M	USD	3 Qtrs
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$1.20M	USD	1 Quarter
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$2.77M	USD	3 Qtrs
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$237.30K	USD	1 Quarter
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$5.80M	USD	3 Qtrs
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$3.87M	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$8.62M	USD	3 Qtrs
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$9.14M	USD	3 Qtrs
Sale of subsidiary shares to non-controlling interest	`SubsidiaryOrEquityMethodInvesteeCumulativeProceedsReceivedOnAllTransactions`	$3.69M	USD	3 Qtrs
Sale of subsidiary shares to non-controlling interest	`SubsidiaryOrEquityMethodInvesteeCumulativeProceedsReceivedOnAllTransactions`	$3.69M	USD	1 Quarter
Common stock issued upon exercise of warrants	`CommonStockIssuedUponExerciseOfWarrants`	$1.74M	USD	1 Quarter
Common stock issued upon exercise of warrants	`CommonStockIssuedUponExerciseOfWarrants`	$2.02M	USD	3 Qtrs
Common stock issued upon exercise of warrants	`CommonStockIssuedUponExerciseOfWarrants`	$1.59M	USD	1 Quarter
Subscription received from sale of subsidiary shares to non-controlling interest	`StockholdersEquityOther`	$501.00K	USD	1 Quarter
Subscription received from sale of subsidiary shares to non-controlling interest	`StockholdersEquityOther`	$501.00K	USD	3 Qtrs
Change in fair value of modified options	`OtherNoncashExpense`	-	USD	3 Qtrs
Change in fair value of modified options	`OtherNoncashExpense`	$666.06K	USD	3 Qtrs
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.89M	USD	3 Qtrs
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$772.59K	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$160.09K	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.57M	USD	3 Qtrs
Preferred stock dividend	`DividendsPreferredStock`	$194.43K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$4.88K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$20.29K	USD	3 Qtrs
Preferred stock dividend	`DividendsPreferredStock`	$780.35K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-19.28M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-5.46M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.15M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.55M	USD	3 Qtrs
Common stock issued upon exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$465.20K	USD	3 Qtrs
Common stock issued upon exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$615.60K	USD	1 Quarter
Common stock issued upon exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$615.60K	USD	3 Qtrs
Common stock issued upon exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$20.36K	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.97M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.25M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.55M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.42M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.08M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.